ResMed Inc. (RSMDF)

Market Cap	35.74B
Revenue (ttm)	5.26B
Net Income (ttm)	1.44B
Shares Out	n/a
EPS (ttm)	9.77
PE Ratio	24.86
Forward PE	21.89
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	40,817
Open	26.73
Previous Close	26.73
Day's Range	26.73 - 26.73
52-Week Range	11.91 - 30.00
Beta	0.87
RSI	53.45
Earnings Date	Jan 22, 2026

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1989
• Employees: 10,600
• Stock Exchange: OTCMKTS
• Ticker Symbol: RSMDF

Financial Performance

In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.